Duchenne-izomdisztrófia: vizsgálatok itt: Grúzia
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in GrúziaSafety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
- Where
- Tbilisi
- Életkor
- 9 év and over
- People
- 36 worldwide
- Run by
- Keros Therapeutics, Inc.
See details and how to joinNCT07704099